Related Experiment Videos
Analysis of the DS86 atomic bomb radiation dosimetry methods using data on severe epilation
1Department of Statistics, Radiation Effects Research Foundation, Hiroshima, Japan.
Radiation Research
|January 1, 1989
Summary
Reanalyzing Hiroshima and Nagasaki radiation data shows the new DS86 dosimetry increases the neutron relative biological effectiveness (RBE) and highlights dose-response nonlinearity. However, DS86 does not significantly improve epilation prediction over T65D dosimetry.
Area of Science:
- Radiation Biology
- Epidemiology
- Dosimetry
Background:
- Severe epilation in Hiroshima and Nagasaki survivors is a key acute radiation effect.
- Previous analyses by Jablon et al. and Gilbert & Ohara examined epilation data.
- Reanalysis uses updated DS86 dosimetry alongside the older T65D system.
Purpose of the Study:
- To reanalyze severe epilation data from Hiroshima and Nagasaki using DS86 and T65D dosimetries.
- To investigate epilation response uniformity across demographic and shielding factors.
- To assess the relative biological effectiveness (RBE) of neutrons and dose-response nonlinearity.
Main Methods:
- Comparative reanalysis of severe epilation data using DS86 and T65D dosimetries.
- Examination of epilation response across shielding categories, sex, and age.
- Analysis of interactions between city, sex, age, and shielding; assessment of RBE and dose-response curves.
Main Results:
- DS86 dosimetry increases the apparent RBE of neutrons versus gamma dose (approx. 5-10) compared to T65D.
- The slope of the dose-response curve (0.75-2.5 Gy) is ~165% steeper with DS86.
- Nonuniformities in epilation response observed with T65D persist with DS86; DS86 is not a better predictor.
Conclusions:
- DS86 dosimetry reveals higher neutron RBE and more pronounced dose-response nonlinearity, including a downturn at high doses.
- The apparent downturn in DS86 is partly due to T65D dose truncation at 600 rad.
- DS86 does not offer improved prediction of epilation response over T65D, despite dosimetry differences.